New Developments in Contraception
This is an internet-based activity that should take 1 hour to complete.
To participate in this webinar learners should:
- Take the pre-test
- Listen to webinar
- Take the post-test
- Complete follow-up evaluation survey
At the conclusion of this activity, participants should be able to:
- Explain the need for new contraceptive methods in the US to improve reproductive health and prevent unintended pregnancy
- Examine the most recent contraceptive technologies to offer new options for patients in the United States
- Describe how new methods will meet patient needs to reduce unintended pregnancy in the US
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hours, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing education requirements of most professional organizations and State Boards of Nursing.
Pharmacists: The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit.
Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
This program is sponsored by the Association of Reproductive Health Professionals.
This project is funded through educational grants from Agile Therapeutics, Teva Pharmaceuticals, and Bayer HealthCare Pharmaceuticals.
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
The intended audiences for this activity are reproductive health professionals, including physicians, nurse midwives, nurse practitioners, physician assistants, pharmacists, students, educators, and researchers.
Advisory Committee Disclosures
Grace Shih, MD, MAS (Planner)
Assistant Clinical ProfessorDr. Shih has no affiliations to disclose.
University of California, San Francisco
Laneta J. Dorflinger, PhD (Planner)
Distinguished ScientistDr. Dorflinger has no affiliations to disclose.
Family Health Institute (FHI 360)
ARHP Staff/Consultant Disclosures
Carole Chrvala, PhD
Consultant (Medical Writer)
Nothing to disclose
Micaela Cohen, MPH, LICSW
Program ManagerNothing to disclose
Beth Jordan Mynett, MD
Nothing to disclose
Amy Swann, MA, CAE
Vice PresidentNothing to disclose